PlainBillCongress, translated.Legislation. Context. Public interest.Referred to the Subcommittee on Courts, the Internet, and Intellectual Property.
Congressional Research Service
Version 00 · Introduced in House · Jun 19, 2003
Medical Independence, Privacy, and Innovation Act of 2003 - Amends the Internal Revenue Code to eliminate language making the medical expense deduction only apply to the extent the relevant expenses exceed 7.5 percent of adjusted gross income. Permits the deduction in computing adjusted gross income.Exempts medical checking accounts from being subjected to certain taxes. Subjects such accounts to taxes on unrelated business income of charitable organizations. Allows a deduction equal to the amount paid in cash to an individual's medical checking account (up to $1,000, or $2,000 in the case of a joint return) and a credit (of up to $1,000) for contributions made to such account.Excludes from gross income any amount paid or distributed out of a medical checking account which is used exclusively to pay qualified medical expenses of any account holder.Decreases the minimum annual deductibles under a high deductible health plan for purposes of Archer medical savings accounts.Makes modifications to regulations regarding the privacy of individually identifiable health information.Prohibits the granting of an exclusive or partially exclusive license regarding an invention made with Federal assistance, except in accordance with specified provisions of Federal law pertaining to the licensing of Federally owned inventions.Amends the Federal Food, Drug, and Cosmetic Act to direct the Secretary to promulgate regulations permitting pharmacists and wholesalers to import prescription drugs from foreign nations, with such regulations to require that each such drug complies with sections of the Act pertaining to new drugs, adulterated drugs and devices, and misbranded drugs and devices, and with other applicable requirements of this Act. (Current law directs the Secretary to promulgate regulations permitting pharmacists and wholesalers to import prescription drugs, except for specified controlled substances and biological products).
People & committees
Rep. Rohrabacher, Dana [R-CA-46] · R–CA
Legislative record
A procedural vote is different from passage. Passage in one chamber does not establish enactment. Explore the glossary.
Referred to the Subcommittee on Courts, the Internet, and Intellectual Property.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Sponsor introductory remarks on measure. (CR H5808-5811)
Referred to the Committee on Ways and Means, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Ways and Means, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Ways and Means, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Ways and Means, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Introduced in House
Primary sources
Text links open the official source. We currently store references to these documents.
Source last updated: Aug 18, 2025. Consult Congress.gov for the current record.
AI Conversation Starters
Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.
Analyze H.R.2544 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.
Examine H.R.2544 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.
Examine H.R.2544 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.
Examine H.R.2544 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.